IDRSF   $16.65  6.97% Market Closed

Idorsia Ltd
Last Events:

2023-03-29 Trend pattern changed from симметричный треугольник to восходящий треугольник.

2023-03-29 Signal in Stochastic changed from bullish to bearish reversal. The stochastic indicator is in the upper part of the neutral territory and left the overbought territory. These factors indicate that perhaps the upside trend is coming to an end price will probably head south Last signal: main and signal line crossing.

2023-03-29 Signal in RSI changed from bullish recovery to bullish weakening. RSI indicator is in the upper part of the neutral territory and it heading south. These factors indicate that the downside trend is forming. Last signal: entrance to the overbought zone.

2023-03-29 Trend pattern changed from восходящий треугольник to симметричный треугольник.

2023-03-29 Signal in Stochastic changed from bearish reversal to bullish. The stochastic indicator is in overbought territory and it heading south. These factors indicate that perhaps the upside trend is coming to an end. Last signal: signal line crossed the middle level.

2023-03-29 Signal in RSI changed from bullish weakening to bullish recovery. RSI indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: exit from the overbought zone.

2023-03-28 Trend pattern changed from симметричный треугольник to восходящий треугольник.

2023-03-28 Signal in Stochastic changed from bullish to bearish reversal. The stochastic indicator is in the upper part of the neutral territory and left the overbought territory. These factors indicate that perhaps the upside trend is coming to an end price will probably head south Last signal: main and signal line crossing.


Current temperature: 0.00
ST: 0, Cor:

50-50 Year Forecast
Low with 50% probability: 15.52
Target: 19.08
High with 50% probability: 22.57
Analyst Recommendations:
Number of estimates 12
Target Price Mean 19.35
Mean unverified/preliminary 19.35 / 19.35
Target Price Low / High 10.51 / 42.04
Median / STD DEV 16.99 / 7.28
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Sell
rsi Sell - -
macd Sell Sell Sell
stoch Sell Sell -
ma20 - - -
ma50 - - -
ma100 - - -
Candlestick PatternJan. 31, 2023 Rickshaw - is a long candlestick with a doji body. In particular, the rickshaw man is a type of long legged doji where the body must be located at or very near the middle of the candle. Indicates indecision in the market.
ISIN CH0363463438
ceo Mr. Jean-Paul Clozel M.D.
Website https://www.idorsia.com
Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases. Its products include PIVLAZ (clazosentan), available in 150 mg, is indicated for the prevention of cerebral vasospasm, vasospasm-related cerebral infarction, and cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage securing; and QUVIVIQ (daridorexant) for the treatment of adult patients with insomnia. The company has a collaboration agreement with Janssen Biotech Inc. to jointly develop and commercialize aprocitentan and its derivative compounds or products; license agreement with Mochida Pharmaceutical for the supply, co-development, and comarketing of daridorexant; and Hoffman-La Roche Inc. to develop and commercialize PIVLAZ. It also has a collaboration with Neurocrine Biosciences, Inc. to develop and commercialize ACT-709478, which is in Phase II clinical trial for the treatment of epilepsy. The company was incorporated in 2017 and is headquartered in Allschwil, Switzerland.